UK Markets closed
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • FTSE 250

    22,263.24
    -451.76 (-1.99%)
     
  • AIM

    1,132.08
    -24.37 (-2.11%)
     
  • GBP/EUR

    1.1942
    -0.0077 (-0.64%)
     
  • GBP/USD

    1.3555
    -0.0045 (-0.3321%)
     
  • BTC-GBP

    25,423.00
    -3,079.19 (-10.80%)
     
  • CMC Crypto 200

    870.86
    +628.18 (+258.85%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.03 (-1.30%)
     
  • CRUDE OIL

    84.83
    -0.72 (-0.84%)
     
  • GOLD FUTURES

    1,836.10
    -6.50 (-0.35%)
     
  • NIKKEI 225

    27,522.26
    -250.64 (-0.90%)
     
  • HANG SENG

    24,965.55
    +13.25 (+0.05%)
     
  • DAX

    15,603.88
    -308.42 (-1.94%)
     
  • CAC 40

    7,068.59
    -125.57 (-1.75%)
     

World Imaging Breast & Prostate Cancer Technologies Research Report 2021: Market Revenue Breakdown for the Main Imaging Modalities, 2020-2026

·3-min read

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Imaging Breast & Prostate Cancer - Technologies, Market Trends and Applications, 2021" report has been added to ResearchAndMarkets.com's offering.

Breast & Prostate cancers have always been in the news due to their widespread occurrence, nature, complexity and aggressiveness. They are the two most commonly found invasive cancers in women and men, respectively.

In the last couple of decades, the detection, localization and diagnosis of these cancers has seen tremendous advances thanks to technology and innovation in the field of Medical imaging, recently focusing on noninvasive optical techniques. Imaging is an important part of cancer clinical protocols and can provide a variety of information about morphology, structure, metabolism and bodily functions.

Biomedical imaging can thus be used in the prediction, staging, screening, prognosis, biopsy guidance for diagnosis, plan of treatment, therapy guidance, therapy response recurrence and palliation of these cancers. With increasing cancer risk globally, there is a higher need for screening and diagnosis as early as possible.

Key Features of the Report

  • Existing, New and Evolving Imaging approaches for detecting and treating Breast & Prostate Cancers

  • Market revenue breakdown for the main Imaging modalities

  • Market forecast of Imaging modalities from 2020-2026

  • Presentation of dominant market trends

  • Summary of ongoing clinical trials, funded projects, investments and M&A's for cancer imaging.

  • Review of most promising upcoming systems/devices

Study Goals and Objectives

  • To provide a thorough analysis of the in vivo imaging modalities for breast and prostate cancer.

  • To summarize the global overview, prevalence, disease progression, trends, regulations and existing facilities for imaging breast and prostate cancer.

  • To detail and describe all the imaging technologies and its market segmentation.

  • To provide the product range, value chain, existing and upcoming market trends and forecast for imaging these cancers.

  • To analyse the technologies and strategies of the various actors and influencers in the value chain.

Key Topics Covered:

1. INTRODUCTION

  • Study Goals and Objectives

  • Information sources and methodology

  • Scope of the report

  • Glossary

  • Definitions

  • List of companies mentioned in the report

2. BREAST & PROSTATE CANCER FACTS

  • Prevalence

  • Scanning & Surgeries

3. TECHNOLOGY SEGMENTATION

  • Existing Technologies

  • Imaging Techniques for Breast & Prostate Cancer

  • Breast Imaging

  • Prostate Imaging

  • Medical Expectations

4. MARKET DATA AND TRENDS

  • Market Segmentation

  • Overview of Key Imaging Systems' manufacturers

  • Market and Forecast

  • Finance & Takeovers

5. NOTICEABLE UPCOMING R & D TECHNOLOGIES

  • Major centres/organisations for clinical trials

  • Funding/Projects

  • Patents' Landscape

  • Major Trends

6. REGULATORY ASPECTS

7. CONCLUSIONS

Companies Mentioned

  • AB-CT

  • Adani

  • AGFA Healthcare

  • Bio Medical International

  • Canon

  • CMR Naviscan,

  • DMS Imaging

  • Ecoray

  • Esaote

  • EXO

  • GE Healthcare

  • Genoray

  • Hologic

  • IMS Giotto,

  • Italray

  • Konica Minolta

  • Koning

  • Landwind Medical

  • Leica Biosystems

  • Lorad,

  • Metaltronica S.P.A.

  • Mindray

  • MS Westfalia

  • Panacea Engineering Medicine,

  • OncoVision

  • Philips

  • Planmed

  • Seno Medical

  • Siemens Healthineers

  • SIUI

  • Shimadzu,

  • Sternmed

  • Toshiba

  • Villa Sistemi Medicali S.P.A.

For more information about this report visit https://www.researchandmarkets.com/r/1l1nvo

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting